{"id":"https://openalex.org/W57196929","doi":null,"title":"The development of nanobodies for therapeutic applications.","display_name":"The development of nanobodies for therapeutic applications.","publication_year":2009,"publication_date":"2009-11-01","ids":{"openalex":"https://openalex.org/W57196929","mag":"57196929","pmid":"https://pubmed.ncbi.nlm.nih.gov/19876789"},"language":"en","primary_location":{"id":"pmid:19876789","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19876789","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008136643","display_name":"Femke Van Bockstaele","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I124674891","display_name":"Ablynx (Belgium)","ror":"https://ror.org/05s030550","country_code":"BE","type":"company","lineage":["https://openalex.org/I124674891"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Femke Van Bockstaele","raw_affiliation_strings":["Ablynx NV, Technologiepark 4, B-9052 Zwijnaarde, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ablynx NV, Technologiepark 4, B-9052 Zwijnaarde, Belgium","institution_ids":["https://openalex.org/I124674891"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068091975","display_name":"Josefin-Beate Holz","orcid":"https://orcid.org/0000-0003-4618-408X","observed_orcids":["https://orcid.org/0000-0003-4618-408X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Josefin-Beate Holz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5055677976","display_name":"Hilde Revets","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hilde Revets","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.2013,"has_fulltext":false,"cited_by_count":141,"citation_normalized_percentile":{"value":0.97009536,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":100},"biblio":{"volume":"10","issue":"11","first_page":"1212","last_page":"24"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nanobodies","display_name":"nanobodies","score":1.0},{"id":"https://openalex.org/keywords/heavy-chain-antibodies","display_name":"heavy-chain antibodies","score":0.7129999995231628},{"id":"https://openalex.org/keywords/camelid-antibodies","display_name":"camelid antibodies","score":0.7979999780654907},{"id":"https://openalex.org/keywords/therapeutic-antibodies","display_name":"therapeutic antibodies","score":0.7760000228881836},{"id":"https://openalex.org/keywords/antibody-engineering","display_name":"antibody engineering","score":0.6000000238418579},{"id":"https://openalex.org/keywords/antibody-structure","display_name":"antibody structure","score":0.3919999897480011},{"id":"https://openalex.org/keywords/antithrombotic-agents","display_name":"antithrombotic agents","score":0.8790000081062317},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.6200000047683716}],"concepts":[{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6502215266227722},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.6460459232330322},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.5436432361602783},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.5225607752799988},{"id":"https://openalex.org/C84613547","wikidata":"https://www.wikidata.org/wiki/Q17037912","display_name":"Heavy chain","level":3,"score":0.5180504322052002},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.43212518095970154},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.41407930850982666},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3865841031074524},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33356067538261414},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3045322895050049},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.13327082991600037}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D002161","descriptor_name":"Camelids, New World","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005343","descriptor_name":"Fibrinolytic Agents","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D005343","descriptor_name":"Fibrinolytic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007128","descriptor_name":"Immunoglobulin Fragments","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007128","descriptor_name":"Immunoglobulin Fragments","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007143","descriptor_name":"Immunoglobulin Heavy Chains","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017321","descriptor_name":"Clinical Trials, Phase I as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061905","descriptor_name":"Single-Domain Antibodies","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D061905","descriptor_name":"Single-Domain Antibodies","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:19876789","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19876789","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Journal Article"},{"id":"mag:57196929","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19876789","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.766700029373169}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2136983907","https://openalex.org/W2966194992","https://openalex.org/W7216197585","https://openalex.org/W4386222120","https://openalex.org/W2794264393","https://openalex.org/W3107819751","https://openalex.org/W2077507635","https://openalex.org/W4322098817","https://openalex.org/W4391138464","https://openalex.org/W3025570080"],"abstract_inverted_index":{"Evolution":[0],"has":[1,47],"been":[2,48],"continuously":[3],"honing":[4],"the":[5,20,24,39,43,72,75,91,109,144,181],"design":[6,76],"of":[7,26,45,56,67,74,77,147,169,180],"antibodies":[8,46,78],"to":[9,18,23,30,50,79],"function":[10],"as":[11],"specific":[12],"molecular":[13],"markers":[14],"that":[15,96],"are":[16,86,108,171,189],"able":[17],"alert":[19],"immune":[21],"system":[22],"presence":[25],"pathogenic":[27],"antigens,":[28],"and":[29,33,126,130,149,163,173],"recruit":[31],"complement-":[32],"Fc":[34],"receptor-bearing":[35],"effector":[36],"cells.":[37],"During":[38],"past":[40],"25":[41],"years,":[42],"versatility":[44],"applied":[49],"several":[51],"therapeutic":[52,87,167],"applications.":[53],"The":[54],"development":[55,83],"new":[57,65],"technologies,":[58],"combined":[59],"with":[60],"data":[61,174],"obtained":[62],"using":[63],"a":[64],"generation":[66],"antibody":[68,113,161],"reagents,":[69],"have":[70],"allowed":[71],"adaptation":[73],"better":[80],"match":[81],"drug":[82,139],"requirements.":[84],"Nanobodies":[85,115],"proteins":[88],"derived":[89],"from":[90,159,175],"heavy-chain":[92],"variable":[93],"(VHH)":[94],"domains":[95,107],"occur":[97],"naturally":[98],"in":[99,103,120],"heavy-chain-only":[100],"Ig":[101],"molecules":[102,135,158],"camelidae.":[104],"These":[105],"VHH":[106],"smallest":[110],"known":[111],"antigen-binding":[112],"fragments.":[114],"can":[116],"be":[117],"easily":[118],"produced":[119],"prokaryotic":[121],"or":[122],"eukaryotic":[123],"host":[124],"organisms,":[125],"their":[127,152],"unique":[128,153],"biophysical":[129],"pharmacological":[131],"characteristics":[132],"render":[133],"these":[134,157],"ideal":[136],"candidates":[137],"for":[138],"development.":[140],"This":[141],"review":[142],"describes":[143],"structural":[145],"properties":[146],"nanobodies":[148,170],"focuses":[150],"on":[151],"features,":[154],"which":[155],"distinguishes":[156],"other":[160],"formats":[162],"small-molecule":[164],"drugs.":[165],"Possible":[166],"applications":[168],"discussed":[172],"phase":[176],"I":[177],"clinical":[178],"trials":[179],"novel":[182],"'first-in-class'":[183],"anti-thrombotic":[184],"agent":[185],"ALX-0081":[186],"(Ablynx":[187],"NV)":[188],"presented.":[190]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":19}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}